Researcher: 'Optical biopsy' for breast cancer increasingly accurateNovember 06, 2009GAINESVILLE, Fla. - Most biopsies following mammograms reveal benign abnormalities, not cancer. But women may not have to endure the medical costs, stress and potential complications that accompany such invasive biopsies forever. A University of Florida biomedical engineering researcher is making progress on an "optical biopsy" that has the potential to determine whether growths are cancerous without ever puncturing the skin. "At this stage, it is just too early for optical tomography to be a screening tool," said Huabei Jiang, the J. Crayton Pruitt Family professor of biomedical engineering, who has spent more than a decade developing the technique at UF and Clemson University. "But you can pretty much say that it is highly likely it can become a diagnostic tool, an adjunct to X-ray mammography." Surgical biopsies have long been the gold standard for determining whether growths are cancerous. But at least three out of four biopsies following mammograms conclude that observed abnormalities are benign and that no intervention was needed, Jiang said. Depending on if the biopsies are performed with needles or surgery, that can mean added cost, recuperation and potential scarring or other complications - all ultimately unnecessary. Jiang has devoted much of his career to an alternative: "phase-contrast diffuse optical tomography," a screening technology that roots out breast cancer not with cutting tools and laboratory tests but with light and computing power. He recently completed the third generation of his apparatus - a bed with an array of fiber optic laser lights and detectors mounted within a hole where the patient places her breast. Light from the harmless lasers enters the breast and scatters. Most gets absorbed in the tissue, but some reaches the detectors. With enough light hitting the detectors from enough different directions, there is sufficient data for Jiang's computer algorithms to create an image of the breast's interior. This image suggests either benign conditions or some of the telltale signs of cancer that are completely invisible to standard X-ray mammograms - for example, a high density of blood vessels snaking around a likely tumor. But the image is just one indicator. In Jiang's newest apparatus, undergoing tests at the Tampa-based Moffitt Cancer Center, fiber optic lights span 10 different wavelengths, or colors. Light with these colors changes in predictable ways when they strike certain compounds, such as oxygenated hemoglobin, water or lipids. Just as light collected from distant planets can reveal the composition of their atmospheres to astronomers, so light collected from these collisions can indicate chemical evidence of cancer. A third technique, known as index refraction or phase contrast, provides information on cellular size and density - both factors that play into determination of cancer in laboratory biopsies. "What he's done is introduce a whole new optical property that is pretty clever," said Steve Ponder, of the phase contrast element of Jiang's research. "It's another tool, and he's reported good success, and it did increase sensitivity." Ponder is director of advanced development for the Fort Lauderdale-based Imaging Diagnostic Systems Inc., which makes breast imaging devices that rely on similar technologies to those Jiang is developing. Over the past 10 years, Jiang and his graduate students have tested their evolving device on a total of about 200 patients, he said. In a 2008 paper in Academic Radiology, his most recently published clinical paper, he obtained 35 images from 33 patients and compared his findings with the results of the women's traditional biopsies. His main conclusion: His technique correctly identified biopsy confirmed malignancies nearly 75 percent of the time, with the most accurate results from older patients, whose softer breasts make abnormalities more prominent. Jiang said he has since boosted the accuracy rate to 91 percent in a study involving 144 women, but he is still readying that study for publication. More research and more patients are needed, he said. "It's still not enough for us to say, 'O.K.'," he said. "But we have some confidence." University of Florida |
|||||||||||||||||||||
| Related Biopsies Current Events and Biopsies News Articles Medicare reimbursement change meant to save money has opposite effect Increased Medicare payments to physicians for outpatient surgeries for bladder cancer have led to a dramatic rise in the number of these procedures being performed and an overall increase in cost to the healthcare system. An alternative method of pancreatic biopsy It is reasonable to obtain a histological diagnosis before treating patients who have pancreatic masses and are unsuitable or unwilling to undergo surgery. 2D protein maps of mucosal biopsies in patients with ileal pouch-anal anastomosis Total proctocolectomy with ileal J-pouch-anal anastomosis (IPAA) is the surgical treatment of choice for patients with refractory ulcerative colitis (UC). Although the surgery generally cures UC allowing a significant improvement of health-related quality of life, complications can occur after IPAA. Report suggests similar effectiveness among options for managing low-risk prostate cancer A comprehensive appraisal of the management and treatment options for low-risk prostate cancer found that the rates of survival and tumor recurrence are similar among the most common treatment approaches, although costs can vary considerably. Jefferson researchers identify possible imaging method to stratify breast cancer without biopsy Scientists from the Kimmel Cancer Center at Jefferson have discovered a possible way for malignant breast tumors to be identified, without the need for a biopsy. Penn Researchers Find Reproductive Germ Cells Survive and Thrive In Transplants, Even Among Species Reproductive researchers from the University of Pennsylvania and The Children's Hospital of Philadelphia have succeeded in isolating and transplanting pure populations of the immature cells that enable male reproduction in two species-human spermatogonia and mouse gonocytes. Researchers finds hidden sensory system in the skin The human sensory experience is far more complex and nuanced than previously thought, according to a groundbreaking new study published in the December 15 issue of the journal Pain. Quitting smoking can reverse asthma-inducing changes in lungs Asthmatic smokers may be able to reverse some of the damage to their lungs that exacerbates asthmatic symptoms just by putting down their cigarettes, according to research out of the University of Groningen in the Netherlands. Targeted breast ultrasound can reduce biopsies for women under 40 Targeted breast ultrasound of suspicious areas of the breast, including lumps, is a safe, reliable and cost-effective alternative to invasive biopsies for women under age 40, according to the findings of two studies presented today at the annual meeting of the Radiological Society of North America (RSNA). Annual screening with breast ultrasound or MRI could benefit some women Results of a large-scale clinical trial presented today at the annual meeting of the Radiological Society of North America (RSNA) provide the first strong evidence of the benefit of annual screening ultrasound for women with dense breasts who are at elevated risk for breast cancer. More Biopsies Current Events and Biopsies News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||